Bicara Therapeutics Inc. (BCAX) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $401.45M | -18.4% |
| 2024 | $491.88M | +430.6% |
| 2023 | -$148.77M | -50.6% |
| 2022 | -$98.80M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $401.45M | -18.4% |
| 2024 | $491.88M | +430.6% |
| 2023 | -$148.77M | -50.6% |
| 2022 | -$98.80M | — |